SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Omeros
An SI Board Since March 2010
Posts SubjectMarks Bans Symbol
464 28 0 OMER
Emcee:  Bradpalm1 Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
439Omeros to Present at the 2017 Wedbush PacGrow Healthcare Conference SEATTLE--(BUHoward Williams-8/10/2017
438OMER short volume volumebot.comJulius Wong18/9/2017
437Saw the news when it hit and yawned. Now up better than 10%. Own some, have vescaram(o)uche-8/4/2017
436OMER treatment of immunoglobulin A nephropathy granted FDA orphan status theflBiotech Jim18/4/2017
435Omeros Corporation to Announce Second Quarter 2017 Financial Results on August 8Howard Williams-8/2/2017
434>>That's funny on speculation Martin could be Doyle or affiliated. I dBiomaven-7/25/2017
433I realized this after thinking about it. I was in irrational exuberance territoBiotech Jim-7/25/2017
432Just catching up with this thread. The S-8 is routine - that's what is fileBiomaven17/24/2017
431OMEROS' 721: POTENTIAL BLOCKBUSTER FIX FOR IMMUNOGLOBULIN A NEPHROPATHY AlaHoward Williams-7/24/2017
430That's funny on speculation Martin could be Doyle or affiliated. I doubt it rkrw-7/6/2017
429It’s been speculated that Art Doyle is Martin Shkreli. For example, this SA postBulbaMan-7/6/2017
428He? Art Doyle as in Sir Arthur Doyle? I assume it could be some hedge fund tharkrw17/6/2017
427Bullish Oneil Trader Omeros article on Seeking Alpha posted today. It mentions CBulbaMan-7/6/2017
426I thought it was originally 3 parts now up to 6. I guess he'll look for a pughmm-7/6/2017
425FWIW on that. twitter.comrkrw-7/6/2017
424Potential OMS 721 competition, parking this Chemocentryx PR here. Original can Biotech Jim-7/6/2017
423Obvious BS piece by "Art Doyle" has been withdrawn ......... scribd.coHoward Williams-7/4/2017
422It seems to be updated as at the bottom of the page it says: “ClinicalTrials.govBulbaMan17/3/2017
421According to the link you posted, I see that this trial was updated back in MarcBiotech Jim-7/3/2017
420Also just posted on clinicaltrials.gov re Omeros Phase 2 trial of OMS721 for IgBulbaMan-7/2/2017
419Thanks BJ! Good catch. Peace & good health, BulbaBulbaMan-7/2/2017
418>>Did not short seller Doyle claim that the company does not have any Ph3 Howard Williams-7/2/2017
417My view is that OMER would be wasting its time in pursuit of the alleged slanderBiotech Jim37/2/2017
416Omeros to pursue legal action against short seller for report that shaved 21% ofJulius Wong-6/29/2017
415Omeros Releases Statement in Response to Recent False Report Date(s): 29-Jun-20Howard Williams-6/29/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News